Medifast Inc. (MED)
Medifast Statistics
Share Statistics
Medifast has 10.94M shares outstanding. The number of shares has increased by 0.39% in one year.
Shares Outstanding | 10.94M |
Shares Change (YoY) | 0.39% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 81.59% |
Shares Floating | 10.64M |
Failed to Deliver (FTD) Shares | 1 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 1.4M, so 12.84% of the outstanding shares have been sold short.
Short Interest | 1.4M |
Short % of Shares Out | 12.84% |
Short % of Float | 13.23% |
Short Ratio (days to cover) | 5.74 |
Valuation Ratios
The PE ratio is 92.1 and the forward PE ratio is 53.83. Medifast's PEG ratio is -0.94.
PE Ratio | 92.1 |
Forward PE | 53.83 |
PS Ratio | 0.32 |
Forward PS | 0.3 |
PB Ratio | 0.92 |
P/FCF Ratio | 11.31 |
PEG Ratio | -0.94 |
Enterprise Valuation
Medifast Inc. has an Enterprise Value (EV) of 659.19M.
EV / Earnings | 315.25 |
EV / Sales | 1.09 |
EV / EBITDA | 229.05 |
EV / EBIT | 229.05 |
EV / FCF | 38.73 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.08.
Current Ratio | 3.34 |
Quick Ratio | 2.68 |
Debt / Equity | 0.08 |
Total Debt / Capitalization | 7.13 |
Cash Flow / Debt | 1.52 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.01% and return on capital (ROIC) is 0.7%.
Return on Equity (ROE) | 0.01% |
Return on Assets (ROA) | 0.01% |
Return on Capital (ROIC) | 0.7% |
Revenue Per Employee | $1,195,363.1 |
Profits Per Employee | $4,148.81 |
Employee Count | 504 |
Asset Turnover | 2.12 |
Inventory Turnover | 3.72 |
Taxes
Income Tax | 1.7M |
Effective Tax Rate | 0.45 |
Stock Price Statistics
The stock price has increased by -63.96% in the last 52 weeks. The beta is 1.17, so Medifast's price volatility has been higher than the market average.
Beta | 1.17 |
52-Week Price Change | -63.96% |
50-Day Moving Average | 14.84 |
200-Day Moving Average | 17.86 |
Relative Strength Index (RSI) | 42.71 |
Average Volume (20 Days) | 225.63K |
Income Statement
In the last 12 months, Medifast had revenue of 602.46M and earned 2.09M in profits. Earnings per share was 0.19.
Revenue | 602.46M |
Gross Profit | 444.62M |
Operating Income | 2.88M |
Net Income | 2.09M |
EBITDA | 2.88M |
EBIT | 2.88M |
Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 90.93M in cash and 16.13M in debt, giving a net cash position of 74.8M.
Cash & Cash Equivalents | 90.93M |
Total Debt | 16.13M |
Net Cash | 74.8M |
Retained Earnings | 176.78M |
Total Assets | 284.21M |
Working Capital | 150.24M |
Cash Flow
In the last 12 months, operating cash flow was 24.48M and capital expenditures -7.45M, giving a free cash flow of 17.02M.
Operating Cash Flow | 24.48M |
Capital Expenditures | -7.45M |
Free Cash Flow | 17.02M |
FCF Per Share | 1.56 |
Margins
Gross margin is 73.8%, with operating and profit margins of 0.48% and 0.35%.
Gross Margin | 73.8% |
Operating Margin | 0.48% |
Pretax Margin | 0.63% |
Profit Margin | 0.35% |
EBITDA Margin | 0.48% |
EBIT Margin | 0.48% |
FCF Margin | 2.83% |
Dividends & Yields
MED pays an annual dividend of $8.23, which amounts to a dividend yield of 8.2%.
Dividend Per Share | $8.23 |
Dividend Yield | 8.2% |
Dividend Growth (YoY) | 0.61% |
Payout Ratio | 4331.58% |
Earnings Yield | 1.38% |
FCF Yield | 11.26% |
Analyst Forecast
The average price target for MED is $16.5, which is 19.5% higher than the current price. The consensus rating is "Hold".
Price Target | $16.5 |
Price Target Difference | 19.5% |
Analyst Consensus | Hold |
Analyst Count | 1 |
Scores
Altman Z-Score | 4.85 |
Piotroski F-Score | 6 |